"Metagenomi Sets IPO Range, Eyes $87M for Gene Editing Biotech"

Metagenomi, a gene editing company, has set a price range for its proposed initial public offering, expecting to raise about $87 million if it prices at $16 per share. The California startup plans to go public later this week by selling 6.25 million shares, with the potential for increased proceeds if the company upsizes before landing on Nasdaq.